IOVA Earnings

Quarterly EPS
$-0.28
Q3 2024
$-0.26
Q4 2024
$-0.36
Q1 2025
$-0.33
Q2 2025
$-0.25
Q3 2025
$-0.18
Q4 2025
$-0.19
Q1 2026
$-0.11
Q2 2026
Latest Revenue99.3M
Latest Net Income-47315000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.1199.3M-47315000+65.7%+66.7%
Q1 2026-$0.1971.4M-79045000+44.8%+47.2%
Q4 2025-$0.1886.8M-71904000+17.7%+30.8%
Q3 2025-$0.2567.5M-91253000+15.2%+10.7%
Q2 2025-$0.3360.0M-111658000+92.7%+2.9%
Q1 2025-$0.3649.3M-116163000+6,798.5%+14.3%
Q4 2024-$0.2673.7M-78559000+15,189.2%+42.2%
Q3 2024-$0.2858.6M-83541000+12,385.1%+39.1%
Q2 2024-$0.3431.1M-97101000
Q1 2024-$0.42715.0K-112976000
Q4 2023-$0.45482.0K-116379000
Q3 2023-$0.46469.0K-113760000
Iovance Biotherapeutics (IOVA) — Earnings